Total Payments
$12,219
2024 Payments
$461.17
Companies
34
Transactions
241
Medicare Patients
703
Medicare Billing
$36,456
Payment Breakdown by Category
Education$7,809 (63.9%)
Food & Beverage$3,664 (30.0%)
Travel$746.75 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $7,809 | 29 | 63.9% |
| Food and Beverage | $3,664 | 206 | 30.0% |
| Travel and Lodging | $746.75 | 6 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $8,550 | 14 | $0 (2024) |
| ABBVIE INC. | $942.53 | 56 | $0 (2023) |
| PFIZER INC. | $326.95 | 23 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $326.05 | 19 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $306.62 | 25 | $0 (2020) |
| Roche Diagnostics Corporation | $212.90 | 10 | $0 (2019) |
| Hologic Sales and Service, LLC | $207.47 | 6 | $0 (2024) |
| Exeltis, USA Inc. | $151.15 | 10 | $0 (2019) |
| Astellas Pharma US Inc | $140.03 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $126.96 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $461.17 | 19 | Sumitomo Pharma America, Inc. ($176.12) |
| 2023 | $9,221 | 54 | Intuitive Surgical, Inc. ($8,437) |
| 2022 | $243.47 | 15 | ABBVIE INC. ($163.70) |
| 2021 | $367.58 | 23 | AbbVie Inc. ($288.50) |
| 2020 | $213.05 | 13 | AbbVie Inc. ($125.55) |
| 2019 | $613.88 | 39 | AbbVie, Inc. ($131.26) |
| 2018 | $600.61 | 45 | AMAG Pharmaceuticals, Inc. ($132.70) |
| 2017 | $498.74 | 33 | Roche Diagnostics Corporation ($96.07) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diagnostics | ||||||
| 10/23/2024 | Hologic Sales and Service, LLC | MYOSURE TISSUE REMOVAL DEVICE (Device) | Food and Beverage | In-kind items and services | $45.26 | General |
| Category: Surgical | ||||||
| 07/29/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: HORMONE THERAPY | ||||||
| 07/01/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: HORMONE THERAPY | ||||||
| 06/04/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: HORMONE THERAPY | ||||||
| 05/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: Rare Disease | ||||||
| 05/23/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: HORMONE THERAPY | ||||||
| 05/23/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: HORMONE THERAPY | ||||||
| 05/16/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: ETONOGESTREL | ||||||
| 05/15/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: HORMONE THERAPY | ||||||
| 04/22/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: HORMONE THERAPY | ||||||
| 04/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Biological | ||||||
| 04/02/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: HORMONE THERAPY | ||||||
| 03/11/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: HORMONE THERAPY | ||||||
| 03/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Biological | ||||||
| 02/12/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 01/23/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: HORMONE THERAPY | ||||||
| 01/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Biological | ||||||
| 01/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $113.34 | General |
| Category: SURGERY | ||||||
| 12/20/2023 | Hologic Sales and Service, LLC | MYOSURE TISSUE REMOVAL DEVICE (Device) | Food and Beverage | In-kind items and services | $45.83 | General |
| Category: Surgical | ||||||
| 12/08/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Biological | ||||||
| 12/06/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: ETONOGESTREL | ||||||
| 11/29/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: WOMENS HEALTH | ||||||
| 10/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Biological | ||||||
| 10/11/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 170 | 198 | $24,735 | $8,782 |
| 2022 | 5 | 198 | 221 | $30,053 | $9,810 |
| 2021 | 4 | 160 | 187 | $27,465 | $9,146 |
| 2020 | 4 | 175 | 200 | $27,931 | $8,718 |
Total Patients
703
Total Services
806
Medicare Billing
$36,456
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 90 | $14,130 | $5,125 | 36.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 53 | 53 | $2,650 | $1,904 | 71.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 25 | 25 | $5,925 | $856.00 | 14.4% |
| 77089 | Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | Office | 2023 | 19 | 19 | $1,425 | $464.32 | 32.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 11 | 11 | $605.00 | $432.30 | 71.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 104 | $16,328 | $5,465 | 33.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 59 | 59 | $2,950 | $2,155 | 73.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 29 | 29 | $6,873 | $982.73 | 14.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,552 | $845.05 | 33.1% |
| 77089 | Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | Office | 2022 | 18 | 18 | $1,350 | $361.61 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 100 | $15,700 | $5,458 | 34.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 47 | 47 | $2,350 | $1,725 | 73.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $3,016 | $1,021 | 33.8% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 27 | 27 | $6,399 | $941.76 | 14.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 72 | 97 | $15,229 | $4,323 | 28.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 62 | 62 | $3,100 | $2,343 | 75.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 23 | 23 | $5,336 | $1,437 | 26.9% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 18 | 18 | $4,266 | $614.91 | 14.4% |
About Dr. Thomas Lane, M.D
Dr. Thomas Lane, M.D is a Obstetrics & Gynecology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1295053320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Lane, M.D has received a total of $12,219 in payments from pharmaceutical and medical device companies, with $461.17 received in 2024. These payments were reported across 241 transactions from 34 companies. The most common payment nature is "Education" ($7,809).
As a Medicare-enrolled provider, Lane has provided services to 703 Medicare beneficiaries, totaling 806 services with total Medicare billing of $36,456. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Tulsa, OK
- Active Since 05/13/2010
- Last Updated 11/15/2022
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1295053320
Products in Payments
- DAVINCI XI (Device) $7,500
- Da Vinci Surgical System (Device) $1,050
- ORILISSA (Drug) $389.45
- MYFEMBREE (Drug) $385.24
- LO LOESTRIN FE (Drug) $311.91
- PREMARIN (Drug) $251.07
- INTRAROSA (Drug) $227.56
- MD cobas Instruments and Reagents (Device) $212.90
- Orilissa (Drug) $187.78
- NEXPLANON (Drug) $150.72
- Vitafol Ultra (Drug) $137.78
- MYOSURE TISSUE REMOVAL DEVICE (Device) $107.02
- Veozah (Drug) $101.69
- SOLOSEC (Drug) $77.72
- Kyleena (Drug) $74.23
- Osphena (Drug) $72.82
- ORIAHNN (Drug) $65.23
- ThinPrep (Device) $64.46
- MAKENA (Drug) $62.67
- CoolSeal Generator (Device) $61.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Tulsa
Dr. Joseph Nemcok, D.o, D.O
Obstetrics & Gynecology — Payments: $607,728
Obstetrics & Gynecology $607,728
Dr. Jay Williamson, D.o, D.O
Obstetrics & Gynecology — Payments: $121,894
Obstetrics & Gynecology $121,894
Katherine Moxley, M.d, M.D
Obstetrics & Gynecology — Payments: $34,382
Obstetrics & Gynecology $34,382
Dr. Lori Hubbard, Md, MD
Obstetrics & Gynecology — Payments: $32,724
Obstetrics & Gynecology $32,724
Dr. Paul Whitham, Do, DO
Obstetrics & Gynecology — Payments: $28,786
Obstetrics & Gynecology $28,786
Micah Relic, Do, DO
Obstetrics & Gynecology — Payments: $20,279
Obstetrics & Gynecology $20,279